Page last updated: 2024-08-26

fibrinogen and Melanoma

fibrinogen has been researched along with Melanoma in 60 studies

Research

Studies (60)

TimeframeStudies, this research(%)All Research%
pre-199030 (50.00)18.7374
1990's9 (15.00)18.2507
2000's9 (15.00)29.6817
2010's8 (13.33)24.3611
2020's4 (6.67)2.80

Authors

AuthorsStudies
Bunch, RT; Hogan, JM; Korman, AJ; Rak, G; Selby, M; Strop, P; Thudium, K; Wang, XT; Zorn, JA1
Daouti, S; David, JM; Dolfi, S; Garman, B; Jacques, MK; Jiang, C; Koenitzer, JD; Kumar, S; Lako, A; Manjarrez-Orduno, N; Mehta, P; Menard, L; Mukherjee, P; Rai, SC1
Barberini, F; Boselli, C; Cannavicci, D; Cirocchi, R; Covarelli, P; De Giorgi, V; Rulli, A1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J1
Fend, F; Goodman, SL; Klein, A; Meyermann, R; Schittenhelm, J; Sipos, B; Tatagiba, MS1
Hamano, A; Jin, T; Ohno, N; Ohno, S; Okumura, N; Saiki, I; Saitoh, Y; Terada, N1
de Vries, EG; Hospers, GA; Mäkelburg, AB; Schröder, CP; van den Brom, RR1
Awsiuk, K; Bernasik, A; Budkowski, A; Lekka, M; Lukes, J; Madej, E; Pabijan, J; Prauzner-Bechcicki, S; Raczkowska, J; Rysz, J; Sepitka, J1
Chung, CY; Dong, C; Ozdemir, T; Robertson, GP; Zhang, P1
Brüggemann, LW; Büller, HR; Esmon, CT; Kamphuisen, PW; Richel, DJ; Spek, CA; van Noorden, CJ; van Sluis, GL1
Edelhauser, G; Gleiss, A; Harmankaya, K; Hoeller, C; Pehamberger, H; Schicher, N; Schindler, K1
Caracò, C; Crispo, A; Di Monta, G; Marone, U; Mozzillo, N1
Clanton, J; Donnelly, E; Gao, X; Geng, L; Giorgio, T; Hallahan, D; Qu, S; Scarfone, C1
BENEDETTO, A; BOSSI, G; ZINA, G1
Advincula, R; Camerer, E; Cornelissen, I; Coughlin, SR; Duong, DN; Qazi, AA1
Bhatia, SK; Fu, W; Hammer, DA; Im, JH; Kowalska, MA; Muschel, RJ; Wang, H1
Caputo, E; Guardiola, J; Lombardi, ML; Luongo, V; Martin, BM; Moharram, R; Pirozzi, G; Tornatore, P1
Adamson, L; Bartůnková, J; Karlsson, G; Lundqvist, A; Masucci, G; Palmborg, A; Pisa, P; Tobiásová-Czetoová, Z1
Bale, WF; Dewey, WC; Harper, PV; Marrack, D; McCardle, RJ; Spar, IL1
Al-Mondhiry, H; Leitzel, K; McGarvey, V1
Collen, D; Matsuo, O; Rijken, DC1
Arbeit, JM; Brennan, MF; Jones, DC; Line, BR; Lowry, SF1
Fujii, K; Imamura, S1
Chen, YP; Diaz-Gonzalez, F; Ginsberg, MH; Leong, L; Liu, BQ; O'Toole, TE1
Fujii, K; Lazarus, GS; Schechter, NM1
Downing, AK; Dwek, RA; Mori, K; Opdenakker, G; Rudd, PM1
Oshikawa, K; Terada, S1
Horton, MA; Teti, A; Townsend, PA; Villanova, I1
Feldman, RI; Howlett, AR; Rosser, MP; Wu, JM1
Ruoslahti, E; Yi, M1
Goodman, SL; Haubner, R; Kessler, H; Mang, C; Schwaiger, M; Senekowitsch-Schmidtke, R; Weber, WA; Wester, HJ; Ziegler, SI1
Honn, KV; Paku, S; Rásó, E; Tímár, J; Tóth, K; Tóvári, J; Trikha, M1
Felding-Habermann, B; Habermann, R; Pilch, J1
Fidler, IJ; Gersten, DM; Hart, IR1
Dintenfass, L; Kammer, S2
Dintenfass, L2
Bergut, FA1
Baba, I; Hayashi, Y; Katagiri, Y; Suzuki, H; Tanoue, K; Yamazaki, H1
Fischer, BE; Will, H1
Atkinson, T; Electricwala, A; Emeis, JJ1
Cheresh, DA; Spiro, RC1
Cheresh, DA; Cooper, HM; Quaranta, V; Smith, JW1
Electricwala, A1
Huang, TF; Knudsen, KA; Niewiarowski, S; Tuszynski, GP1
Kawachi, S1
Markland, FS1
Edgington, TS; Plow, EF1
Dintenfass, L; Forbes, CD; Milton, GW; Stewart, JH1
Dintenfass, L; Milton, GW1
Bettigole, RE; Clifford, GO; Himelstein, ES; Oettgen, HF1
Galton, DA; Hamilton-Fairley, G; Malpas, JS1
Damasio, EE; Marmont, AM1
Hagmar, B1
Gallmeier, WM; Schmidt, CG; Stier, HW1
Shulman, NR; Watkins, SP1
Almersjö, O; Bengmark, S; Hafström, LO; Korsan-Bengtsen, K; Ygge, J1
Haustein, UF1

Reviews

4 review(s) available for fibrinogen and Melanoma

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021
Vemurafenib-Induced Disseminated Intravascular Coagulation in Metastatic Melanoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Dec-20, Volume: 33, Issue:36

    Topics: Acute Disease; Antineoplastic Agents; Biomarkers; Biomarkers, Tumor; Brain Neoplasms; Databases, Factual; Disseminated Intravascular Coagulation; Drug Administration Schedule; Fatal Outcome; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Indoles; L-Lactate Dehydrogenase; Male; Melanoma; Middle Aged; Mutation; Pharmacovigilance; Platelet Count; Proto-Oncogene Proteins B-raf; Recurrence; S100 Calcium Binding Protein beta Subunit; Skin Neoplasms; Sulfonamides; Tumor Burden; Vemurafenib

2015
The biology of cancer invasion and metastasis.
    Advances in cancer research, 1978, Volume: 28

    Topics: Animals; Cell Adhesion; Cell Cycle; Cell Division; Cell Membrane; Cell Movement; Cell Survival; Embolism; Fibrinogen; Glucosyltransferases; Humans; Immunity, Cellular; Inflammation; Lymph Nodes; Lymphatic Metastasis; Melanoma; Membrane Lipids; Membrane Proteins; Mice; Microcirculation; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Neoplasms, Experimental; Neoplastic Cells, Circulating; Platelet Aggregation; Surface Properties; Thoracic Duct

1978
Re-evaluation of heat precipitation method for plasma fibrinogen estimation: effect of abnormal proteins and plasma viscosity.
    Journal of clinical pathology, 1976, Volume: 29, Issue:2

    Topics: Anticoagulants; Blood Coagulation Tests; Blood Viscosity; Chemical Precipitation; Cryoglobulins; Dextrans; Fibrinogen; Glucose; Hot Temperature; Humans; Kidney Failure, Chronic; Melanoma; Multiple Myeloma; Myeloma Proteins; Serum Albumin

1976

Trials

2 trial(s) available for fibrinogen and Melanoma

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021
Collagen sealant patch to reduce lymphatic drainage after lymph node dissection.
    World journal of surgical oncology, 2012, Dec-19, Volume: 10

    Topics: Adult; Aged; Aged, 80 and over; Axilla; Collagen; Drainage; Drug Combinations; Female; Fibrin Tissue Adhesive; Fibrinogen; Groin; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Prospective Studies; Seroma; Skin Neoplasms; Thrombin

2012

Other Studies

55 other study(ies) available for fibrinogen and Melanoma

ArticleYear
Preclinical Characterization of Relatlimab, a Human LAG-3-Blocking Antibody, Alone or in Combination with Nivolumab.
    Cancer immunology research, 2022, 10-04, Volume: 10, Issue:10

    Topics: Animals; Antibodies, Blocking; Antibodies, Monoclonal; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; CTLA-4 Antigen; Fibrinogen; Humans; Immune Checkpoint Inhibitors; Macaca fascicularis; Melanoma; Mice; Nivolumab; Programmed Cell Death 1 Receptor

2022
Comprehensive immunophenotyping of solid tumor-infiltrating immune cells reveals the expression characteristics of LAG-3 and its ligands.
    Frontiers in immunology, 2023, Volume: 14

    Topics: CTLA-4 Antigen; Fibrinogen; Humans; Immunophenotyping; Leukocytes, Mononuclear; Ligands; Melanoma; Programmed Cell Death 1 Receptor; Tumor Microenvironment

2023
Reduction of postoperative lymphorrhoea in patients undergoing radical lymphadenectomy for stage III melanoma: prospective study using collagen-fibrin patches.
    Minerva chirurgica, 2020, Volume: 75, Issue:2

    Topics: Axilla; Drug Combinations; Female; Fibrinogen; Humans; Inguinal Canal; Lymph; Lymph Node Excision; Lymphatic Metastasis; Lymphedema; Male; Melanoma; Neoplasm Staging; Postoperative Complications; Prospective Studies; Retrospective Studies; Skin Neoplasms; Thrombin

2020
Comparing the expression of integrins αvβ3, αvβ5, αvβ6, αvβ8, fibronectin and fibrinogen in human brain metastases and their corresponding primary tumors.
    International journal of clinical and experimental pathology, 2013, Volume: 6, Issue:12

    Topics: Antigens, Neoplasm; Biomarkers, Tumor; Biopsy; Brain Neoplasms; Carcinoma; Female; Fibrinogen; Fibronectins; Humans; Immunohistochemistry; Integrin alphaVbeta3; Integrins; Male; Melanoma; Prognosis; Receptors, Vitronectin; Skin Neoplasms

2013
Imaging of thrombosis and microcirculation in mouse lungs of initial melanoma metastasis with in vivo cryotechnique.
    Microvascular research, 2014, Volume: 91

    Topics: Animals; Blood Coagulation; Blood Platelets; Cell Line, Tumor; Fibrinogen; Freezing; Glutathione; Lung; Lung Neoplasms; Male; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Microcirculation; Neoplasm Metastasis; Neoplasm Transplantation; Platelet Activation; Platelet Aggregation; Quantum Dots; src-Family Kinases; Thrombosis

2014
PDMS substrate stiffness affects the morphology and growth profiles of cancerous prostate and melanoma cells.
    Journal of the mechanical behavior of biomedical materials, 2015, Volume: 41

    Topics: Biomechanical Phenomena; Cell Line, Tumor; Cell Proliferation; Dimethylpolysiloxanes; Elasticity; Fibrinogen; Humans; Male; Mechanical Phenomena; Melanoma; Microchip Analytical Procedures; Prostatic Neoplasms; Surface Properties

2015
Sequential binding of αVβ3 and ICAM-1 determines fibrin-mediated melanoma capture and stable adhesion to CD11b/CD18 on neutrophils.
    Journal of immunology (Baltimore, Md. : 1950), 2011, Jan-01, Volume: 186, Issue:1

    Topics: Animals; Blood Flow Velocity; CD11b Antigen; CD18 Antigens; Cell Adhesion; Cell Communication; Cell Line, Tumor; Fibrin; Fibrinogen; Humans; Inflammation Mediators; Integrin alphaVbeta3; Intercellular Adhesion Molecule-1; Melanoma; Mice; Neutrophil Infiltration; Thrombosis

2011
Endogenous activated protein C is essential for immune-mediated cancer cell elimination from the circulation.
    Cancer letters, 2011, Jul-01, Volume: 306, Issue:1

    Topics: Animals; Antigens, CD; Blood Coagulation; Blood Platelets; Cadherins; Fibrinogen; Immune System; Lung Neoplasms; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, SCID; Neoplasm Metastasis; Protein C; Receptors, Lysosphingolipid; Thrombin

2011
Pretherapeutic laboratory findings, extent of metastasis and choice of treatment as prognostic markers in ocular melanoma- a single centre experience.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2013, Volume: 27, Issue:3

    Topics: Albumins; Biomarkers; C-Reactive Protein; Disease-Free Survival; Female; Fibrinogen; Humans; L-Lactate Dehydrogenase; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Prognosis; Retrospective Studies; Uveal Neoplasms

2013
Integrin-mediated targeting of drug delivery to irradiated tumor blood vessels.
    Cancer cell, 2003, Volume: 3, Issue:1

    Topics: Albumins; Animals; Antigens, Neoplasm; Bacteriophage T7; Drug Carriers; Drug Delivery Systems; Fibrinogen; Glioma; Integrins; Iodine Radioisotopes; Liposomes; Melanoma; Mice; Nanotechnology; Neoplasm Transplantation; Neoplasms; Peptides; Radioimmunotherapy; Regional Blood Flow; Tumor Cells, Cultured; Ultrasonography, Doppler

2003
[Demonstration].
    Nederlandsch tijdschrift voor verloskunde en gynaecologie, 1957, Volume: 57, Issue:3

    Topics: Afibrinogenemia; Female; Fibrinogen; Hemorrhagic Disorders; Humans; Medical Records; Melanoma; Vaginal Neoplasms

1957
[I-131 LABELED FIBRINOGEN IN THE DIAGNOSIS OF CUTANEOUS NEOPLASMS. PREVENTIVE NOTE].
    Minerva dermatologica, 1964, Volume: 39

    Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fibrinogen; Genetic Diseases, X-Linked; Hemangioma; Histiocytoma, Benign Fibrous; Humans; Iodine Isotopes; Leukemia, Hairy Cell; Lymphatic Diseases; Melanoma; Neoplasms; Radiometry; Severe Combined Immunodeficiency; Skin Neoplasms; Skin Ulcer

1964
Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis.
    Blood, 2004, Jul-15, Volume: 104, Issue:2

    Topics: Animals; Blood Platelets; Cell Line, Tumor; Disease Models, Animal; Female; Fibrinogen; Male; Melanoma; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Neoplasm Transplantation; Neoplastic Cells, Circulating; Receptor, PAR-1; Receptor, PAR-2; Receptors, Thrombin; Skin Neoplasms

2004
Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation.
    Cancer research, 2004, Dec-01, Volume: 64, Issue:23

    Topics: Adenocarcinoma; Animals; Blood Coagulation; Blood Platelets; Cell Communication; Cell Line, Tumor; Colonic Neoplasms; Fibrinogen; Fibrosarcoma; Hirudins; Humans; Lung; Lung Neoplasms; Melanoma; Melanoma, Experimental; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasms; Neoplastic Cells, Circulating; Rats; Thrombin

2004
Peptide profiling in epithelial tumor plasma by the emerging proteomic techniques.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2005, May-05, Volume: 819, Issue:1

    Topics: Adult; Aged; Alpha-Globulins; Amino Acid Sequence; Breast Neoplasms; Chromatography, High Pressure Liquid; Female; Fibrinogen; Gene Expression Profiling; Humans; Lasers; Male; Mass Spectrometry; Melanoma; Neoplasm Proteins; Peptides; Proteomics; Skin Neoplasms

2005
Effects of human plasma proteins on maturation of monocyte-derived dendritic cells.
    Immunology letters, 2005, Sep-15, Volume: 100, Issue:2

    Topics: Antigens, CD; Blood Proteins; CD83 Antigen; Cell Differentiation; Cells, Cultured; Dendritic Cells; Dose-Response Relationship, Drug; Fibrinogen; Humans; Immunoglobulins; Immunophenotyping; Lymphocyte Culture Test, Mixed; Melanoma; Membrane Glycoproteins; Monocytes

2005
131-I-labeled antibodies to human fibrinogen. Diagnostic studies and therapeutic trials.
    Cancer, 1967, Volume: 20, Issue:5

    Topics: Antibodies; Antifibrinolytic Agents; Brain Neoplasms; Breast Neoplasms; Carcinoma; Fibrinogen; Fibrinolytic Agents; Humans; Iodine Isotopes; Iodine Radioisotopes; Melanoma; Neoplasms; Radionuclide Imaging; Sarcoma

1967
Interaction of human tumor cells with human platelets and the coagulation system.
    Thrombosis and haemostasis, 1983, Oct-31, Volume: 50, Issue:3

    Topics: Adenocarcinoma; Blood Platelets; Breast Neoplasms; Cell Line; Cells, Cultured; Factor VII; Factor X; Fibrin; Fibrinogen; Hemostasis; Humans; In Vitro Techniques; Iodine Radioisotopes; Melanoma

1983
Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Thrombosis and haemostasis, 1981, Jun-30, Volume: 45, Issue:3

    Topics: alpha-2-Antiplasmin; Endopeptidases; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; In Vitro Techniques; Iodine Radioisotopes; Isotope Labeling; Melanoma; Plasminogen; Plasminogen Activators; Urokinase-Type Plasminogen Activator

1981
Deep venous thromboembolism in patients undergoing inguinal lymph node dissection for melanoma.
    Annals of surgery, 1981, Volume: 194, Issue:5

    Topics: Bed Rest; Double-Blind Method; Female; Fibrinogen; Heparin; Humans; Iodine Radioisotopes; Lymph Node Excision; Male; Melanoma; Middle Aged; Neoplasm Staging; Pulmonary Embolism; Risk; Thrombophlebitis

1981
Cell surface proteolysis by serine proteinases enhances RGD-sensitive melanoma cell adhesion on fibrinogen and vitronectin.
    Experimental cell research, 1995, Volume: 220, Issue:1

    Topics: Amino Acid Sequence; Cell Adhesion; Chymotrypsin; Extracellular Matrix Proteins; Fibrinogen; Fibrinolysin; Glycoproteins; Humans; Integrins; Laminin; Melanoma; Molecular Sequence Data; Oligopeptides; Receptors, Cytoadhesin; Receptors, Vitronectin; Serine Endopeptidases; Trypsin; Tumor Cells, Cultured; Up-Regulation; Vitronectin

1995
Beta 3 integrin-mediated fibrin clot retraction by nucleated cells: differing behavior of alpha IIb beta 3 and alpha v beta 3.
    Blood, 1995, Oct-01, Volume: 86, Issue:7

    Topics: Animals; Antibodies; Antigens, CD; Cell Line; CHO Cells; Clot Retraction; Cricetinae; Endothelium, Vascular; Fibrin; Fibrinogen; Gene Expression; Humans; Immunosorbent Techniques; Integrin beta3; Integrins; Melanoma; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Cytoadhesin; Receptors, Vitronectin; Recombinant Proteins; Transfection; Tumor Cells, Cultured

1995
Modification of integrin-mediated cell attachment to substrata by serine proteinases in the presence and absence of divalent cations.
    Experimental cell research, 1993, Volume: 208, Issue:1

    Topics: Amino Acid Sequence; Calcium; Cations, Divalent; Cell Adhesion; Chymotrypsin; Extracellular Matrix; Fibrinogen; Fibronectins; Glycoproteins; Humans; In Vitro Techniques; Integrins; Laminin; Melanoma; Molecular Sequence Data; Molecular Weight; Oligopeptides; Tumor Cells, Cultured; Vitronectin

1993
The activation of type 1 and type 2 plasminogen by type I and type II tissue plasminogen activator.
    The Journal of biological chemistry, 1995, Feb-17, Volume: 270, Issue:7

    Topics: Amino Acid Sequence; Chromatography, Affinity; Cysteine; Disulfides; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Fibrinogen; Glycosylation; Humans; Isoenzymes; Kinetics; Macromolecular Substances; Melanoma; Models, Molecular; Molecular Weight; Peptide Fragments; Plasminogen; Plasminogen Activator Inhibitor 1; Protein Structure, Secondary; Tissue Plasminogen Activator; Tumor Cells, Cultured

1995
Ussuristatin 2, a novel KGD-bearing disintegrin from Agkistrodon ussuriensis venom.
    Journal of biochemistry, 1999, Volume: 125, Issue:1

    Topics: Agkistrodon; Amino Acid Sequence; Animals; Cell Adhesion; Crotalid Venoms; Dimerization; Disintegrins; Fibrinogen; Fibronectins; Humans; Melanoma; Molecular Sequence Data; Platelet Aggregation; Platelet Aggregation Inhibitors; Sequence Homology, Amino Acid; Tumor Cells, Cultured; Viper Venoms

1999
Beta1 integrin antisense oligodeoxynucleotides: utility in controlling osteoclast function.
    European journal of cell biology, 1999, Volume: 78, Issue:7

    Topics: Animals; Base Sequence; Blood Proteins; Bone Marrow Cells; Bone Resorption; Calcitonin; Cell Adhesion; Cells, Cultured; Collagen; Dentin; Dimerization; Down-Regulation; Extracellular Matrix Proteins; Fibrinogen; Fibronectins; Gene Expression Regulation; Glass; Humans; Integrin beta1; Integrins; Melanoma; Molecular Sequence Data; Oligonucleotides, Antisense; Osteoclasts; Rabbits; Receptors, Collagen; Receptors, Vitronectin; Sequence Alignment; Sequence Homology, Nucleic Acid; Tumor Cells, Cultured; Vitronectin

1999
A cell-based adhesion assay for the characterization of integrin alpha v beta 3 antagonists.
    Methods in molecular biology (Clifton, N.J.), 1999, Volume: 129

    Topics: Amino Acid Sequence; Antibodies; Cell Adhesion; Cell Culture Techniques; Fibrinogen; Humans; Indicators and Reagents; Melanoma; Oligopeptides; Receptors, Vitronectin; Tumor Cells, Cultured

1999
A fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis.
    Proceedings of the National Academy of Sciences of the United States of America, 2001, Jan-16, Volume: 98, Issue:2

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fibrinogen; Fibronectins; Humans; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Neovascularization, Pathologic; Osteosarcoma; Peptide Fragments; Receptors, Vitronectin; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2001
Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography.
    Cancer research, 2001, Mar-01, Volume: 61, Issue:5

    Topics: Animals; Azides; Biomarkers, Tumor; DNA-Binding Proteins; Female; Fibrinogen; Fluorine Radioisotopes; Galactose; Humans; Isotope Labeling; Melanoma; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Osteosarcoma; Peptides, Cyclic; Radiopharmaceuticals; Receptors, Vitronectin; Tissue Distribution; Tomography, Emission-Computed; Transcription Factors; Transplantation, Heterologous; Vitronectin

2001
Ectopic alphaIIbbeta3 integrin signaling involves 12-lipoxygenase- and PKC-mediated serine phosphorylation events in melanoma cells.
    Thrombosis and haemostasis, 2001, Volume: 85, Issue:6

    Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Animals; Antibodies, Monoclonal; Arachidonate 12-Lipoxygenase; Cell Adhesion; Enzyme Inhibitors; Fibrinogen; Flow Cytometry; Melanoma; Mice; Microscopy, Confocal; Phosphorylation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Kinase C; Serine; Signal Transduction; Tumor Cells, Cultured

2001
Unique ability of integrin alpha(v)beta 3 to support tumor cell arrest under dynamic flow conditions.
    The Journal of biological chemistry, 2002, Jun-14, Volume: 277, Issue:24

    Topics: Actins; Antineoplastic Agents; Calcium; Cell Adhesion; Cell Membrane; Cross-Linking Reagents; Dose-Response Relationship, Drug; Fibrinogen; Humans; Ligands; Melanoma; Microscopy, Fluorescence; Protein Binding; Receptors, Vitronectin; Time Factors; Tumor Cells, Cultured

2002
Plasma viscosity in 615 subjects. Effect of fibrinogen, globulin, and cholesterol in normals, peripheral vascular disease retinopathy, and melanoma.
    Biorheology, 1977, Volume: 14, Issue:5-6

    Topics: Blood Viscosity; Cholesterol; Fibrinogen; Humans; Male; Melanoma; Retinal Diseases; Serum Globulins; Vascular Diseases

1977
Some aspects of haemorrheology of metastasis in malignant melanoma.
    Haematologia, 1977, Volume: 11, Issue:3-4

    Topics: ABO Blood-Group System; Adult; Blood Coagulation; Blood Viscosity; Erythrocyte Aggregation; Female; Fibrinogen; Hematocrit; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Rheology; Serum Globulins

1977
[Blood coagulation and fibrinolysis system in malignant melanoma of the skin].
    Sovetskaia meditsina, 1978, Issue:10

    Topics: Adolescent; Adult; Blood Coagulation; Blood Coagulation Tests; Female; Fibrinogen; Fibrinolysis; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Remission, Spontaneous; Skin Neoplasms

1978
Elevation of plasma viscosity and of aggregation of red cells in melanoma metastasis.
    Biorheology, 1978, Volume: 15, Issue:2

    Topics: Adult; Blood Viscosity; Erythrocyte Aggregation; Female; Fibrinogen; Humans; Male; Melanoma; Neoplasm Metastasis; Serum Albumin; Serum Globulins; Sex Factors; Time Factors

1978
Characterization of platelet aggregation induced by the human melanoma cell line HMV-I: roles of heparin, plasma adhesive proteins, and tumor cell membrane proteins.
    Cancer research, 1991, Feb-15, Volume: 51, Issue:4

    Topics: Antibodies, Monoclonal; Azepines; Blood Coagulation Factors; Calcium; Cells, Cultured; Citrates; Citric Acid; Fibrinogen; Flow Cytometry; Heparin; In Vitro Techniques; Magnesium; Melanoma; Membrane Proteins; Microbial Collagenase; Neuraminidase; Platelet Activating Factor; Platelet Aggregation; Platelet Membrane Glycoproteins; Thrombospondins; Triazoles; Trypsin

1991
Effects of intact fibrin and partially plasmin-degraded fibrin on kinetic properties of one-chain tissue-type plasminogen activator.
    Biochimica et biophysica acta, 1990, Oct-18, Volume: 1041, Issue:1

    Topics: Amino Acid Sequence; Fibrin; Fibrinogen; Fibrinolysin; Humans; Kinetics; Melanoma; Molecular Sequence Data; Oligopeptides; Peptide Fragments; Substrate Specificity; Tissue Plasminogen Activator; Tumor Cells, Cultured

1990
Evaluation of epithelial tissue plasminogen activator as a thrombolytic agent in a rabbit model of venous thrombosis.
    The Journal of pharmacology and experimental therapeutics, 1986, Volume: 238, Issue:1

    Topics: alpha-2-Antiplasmin; Animals; Disease Models, Animal; Epithelium; Fibrinogen; Fibrinolysis; Fibroblasts; Humans; Keratins; Melanoma; Partial Thromboplastin Time; Phlebitis; Plasminogen Activators; Rabbits; Rats

1986
Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor.
    The Journal of biological chemistry, 1987, Dec-25, Volume: 262, Issue:36

    Topics: Cell Adhesion; Cell Line; Chromatography, Affinity; Fibrinogen; Flow Cytometry; Fluorescent Antibody Technique; Glycoproteins; Humans; Melanoma; Oligopeptides; Receptors, Immunologic; Receptors, Peptide; Tumor Cells, Cultured; Vitronectin; von Willebrand Factor

1987
A novel vitronectin receptor integrin (alpha v beta x) is responsible for distinct adhesive properties of carcinoma cells.
    Cell, 1989, Apr-07, Volume: 57, Issue:1

    Topics: Adenocarcinoma; Amino Acid Sequence; Blotting, Northern; Cell Adhesion; Cell Line; Electrophoresis, Gel, Two-Dimensional; Fibrinogen; Fibroblasts; Fibronectins; Glycoproteins; Humans; Integrins; Lung Neoplasms; Melanoma; Membrane Glycoproteins; Receptors, Immunologic; Receptors, Vitronectin; RNA, Messenger; Vitronectin; von Willebrand Factor

1989
Lectin affinity bioassay: an assay method for glycoprotein enzyme.
    Biochimica et biophysica acta, 1989, Jan-27, Volume: 990, Issue:1

    Topics: Alkaline Phosphatase; Biological Assay; Concanavalin A; Fibrinogen; Glycoproteins; Lectins; Melanoma; Plasminogen; Tissue Plasminogen Activator; Tumor Cells, Cultured

1989
Trigramin, an RGD-containing peptide from snake venom, inhibits cell-substratum adhesion of human melanoma cells.
    Experimental cell research, 1988, Volume: 179, Issue:1

    Topics: Cell Adhesion; Cells, Cultured; Fibrinogen; Fibronectins; Humans; Integrins; Intercellular Signaling Peptides and Proteins; Melanoma; Membrane Glycoproteins; Microscopy, Phase-Contrast; Oligopeptides; Peptides; Snake Venoms

1988
[The inhibitory effect of batroxobin against the lung metastasis of the B16-F10 melanoma cells implanted in the mice in relation to the activity of the NK cell].
    Nihon Ika Daigaku zasshi, 1988, Volume: 55, Issue:2

    Topics: Animals; Batroxobin; Cytotoxicity, Immunologic; Fibrinogen; Killer Cells, Natural; Lung Neoplasms; Male; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Serine Endopeptidases

1988
Antitumor action of crotalase, a defibrinogenating snake venom enzyme.
    Seminars in thrombosis and hemostasis, 1986, Volume: 12, Issue:4

    Topics: Animals; Antineoplastic Agents; Cells, Cultured; Endopeptidases; Fibrinogen; Isoflurophate; Melanoma; Mice; Mice, Inbred C57BL; Mitosis; Serine Endopeptidases

1986
Discriminating neoantigenic differences between fibrinogen and fibrin derivatives.
    Proceedings of the National Academy of Sciences of the United States of America, 1973, Volume: 70, Issue:4

    Topics: Abruptio Placentae; Acute Kidney Injury; Adenocarcinoma; Binding Sites, Antibody; Binding, Competitive; Blood Coagulation Disorders; Epitopes; Female; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Immune Sera; Iodine Isotopes; Male; Melanoma; Meningococcal Infections; Peritonitis; Pregnancy; Prostatic Neoplasms; Radioimmunoassay; Structure-Activity Relationship

1973
Influence of ABO blood groups and fibrinogen on thrombus formation and aggregation of red cells in cardiovascular and malignant diseases: new aspects of biorheological characterization of disease.
    Biorheology, 1973, Volume: 10, Issue:4

    Topics: ABO Blood-Group System; Blood Coagulation; Blood Sedimentation; Blood Viscosity; Cardiovascular Diseases; Cell Aggregation; Diabetes Mellitus; Erythrocytes; Fibrinogen; Graft Rejection; Hematocrit; Hemophilia A; Humans; Hyperthyroidism; Kidney Failure, Chronic; Kidney Transplantation; Melanoma; Myocardial Infarction; Prognosis; Rheology; Serum Albumin; Thrombosis; Transplantation, Homologous

1973
Blood viscosity factors and prognosis in malignant melanoma. Effect of abo blood groups.
    The Medical journal of Australia, 1973, Jun-02, Volume: 1, Issue:22

    Topics: ABO Blood-Group System; Adult; Aged; Blood Sedimentation; Blood Viscosity; Female; Fibrinogen; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Prognosis; Serum Albumin

1973
Hypofibrinogenemia due to L-asparaginase: studies of fibrinogen survival using autologous 131-I-fibrinogen.
    Blood, 1970, Volume: 35, Issue:2

    Topics: Adenocarcinoma; Adult; Afibrinogenemia; Asparaginase; Breast Neoplasms; Female; Fibrinogen; Humans; Iodine Radioisotopes; Leukemia, Myeloid; Lymphoma, Large B-Cell, Diffuse; Male; Melanoma; Middle Aged; Neuroblastoma

1970
Clinical experience with L-asparaginase.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1970, Volume: 33

    Topics: Asparaginase; Bone Marrow Cells; Child; Drug Hypersensitivity; Erwinia; Escherichia coli; Female; Fibrinogen; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukocyte Count; Liver Function Tests; Lymphoma, Non-Hodgkin; Melanoma; Nausea; Serum Albumin; Species Specificity; Vomiting

1970
Some clinical observations on the treatment with L-asparaginase of the acute leukemias.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1970, Volume: 33

    Topics: Acute Disease; Adolescent; Adult; Aged; Asparaginase; Blood Chemical Analysis; Blood Platelets; Body Temperature; Bone Marrow Examination; Chemical and Drug Induced Liver Injury; Child; Erythrocyte Count; Escherichia coli; Fibrinogen; Hemoglobins; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Melanoma; Uric Acid

1970
Defibrination and metastasis formation: effects of arvin on experimental metastases in mice.
    European journal of cancer, 1972, Volume: 8, Issue:1

    Topics: Animals; Anticoagulants; Blood Coagulation; Fibrinogen; Melanoma; Mice; Neoplasm Metastasis; Neoplasms, Experimental; Sarcoma, Experimental; Time Factors; Venoms

1972
[On blood coagulation disorders during enzyme therapy of malignant tumors and hemoblastoses].
    Deutsche medizinische Wochenschrift (1946), 1969, Feb-07, Volume: 94, Issue:6

    Topics: Adenocarcinoma; Adolescent; Adult; Aged; Asparaginase; Blood Coagulation Disorders; Blood Platelets; Bone Neoplasms; Child; Choroid Neoplasms; Factor V; Factor VIII; Female; Fibrinogen; Fibrinolysis; Humans; Leukemia, Lymphoid; Male; Melanoma; Neoplasm Metastasis; Plasmacytoma; Thrombelastography

1969
Platelet cold agglutinins.
    Blood, 1970, Volume: 36, Issue:2

    Topics: Adult; Aged; Animals; Antibodies; Antigen-Antibody Reactions; Blood Platelets; Carcinoma, Squamous Cell; Cold Temperature; Felty Syndrome; Female; Fibrinogen; Hemagglutination Tests; Hepatitis B; Humans; Hypersplenism; Immunochemistry; Immunoglobulins; Male; Melanoma; Middle Aged; Molecular Weight; Neoplasm Metastasis; Rabbits; Thrombocytopenia

1970
Changes in coagulation factors after hepatic dearterialization in man.
    American journal of surgery, 1968, Volume: 116, Issue:3

    Topics: Aged; Blood Coagulation Factors; Eye Neoplasms; Factor VII; Factor X; Female; Fibrinogen; Hepatic Artery; Humans; Leiomyosarcoma; Liver; Liver Neoplasms; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Peritoneal Neoplasms; Prothrombin; Sigmoid Neoplasms

1968
[The localization of the tissue activator of fibrinolysis in skin tumors].
    Archiv fur klinische und experimentelle Dermatologie, 1969, Volume: 234, Issue:2

    Topics: Connective Tissue; Ectoderm; Fibrinogen; Fibrinolysis; Hemangioma; Humans; Melanoma; Skin Neoplasms; Thrombin; Thrombosis

1969
chemdatabank.com